Want to join the conversation?
$CAH, which competes with $MCK, $ABC, and $OMI, said its largest contributing segment Pharmaceutical reported a rise in 2Q16 revenue of 25% to $28.3Bil and segment profit rose 16%. Medical segment also reported a rise in revenue of 9% YoverY while segment profit fell 8% related to Cordis-related inventory fair value step-up.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?